Literature DB >> 28837791

Morphologic and Functional Retinal Vessel Changes in Branch Retinal Vein Occlusion: An Optical Coherence Tomography Angiography Study.

Yuto Iida1, Yuki Muraoka2, Sotaro Ooto1, Kiyoshi Suzuma1, Tomoaki Murakami1, Yuko Iida-Miwa1, Rima Ghashut1, Akitaka Tsujikawa1.   

Abstract

PURPOSE: The present study aimed to investigate the morphology of the retinal vasculature in eyes with branch retinal vein occlusion (BRVO) using optical coherence tomography (OCT) angiography.
DESIGN: Observational case series.
METHODS: Fluorescein angiography (FA) and OCT angiography were used to examine macular area and the retinal vasculature at the affected arteriovenous (AV) crossing in 46 patients with BRVO.
RESULTS: FA revealed that the affected AV crossing pattern involved arterial overcrossing in 23 eyes (50.0%) and venous overcrossing in 11 eyes (23.9%). However, FA failed to detect the crossing pattern in 10 eyes (21.7%). OCT angiography was significantly more effective for identification of the AV crossing pattern than FA (44 eyes; 95.7%; P = .013). The number of eyes with venous overcrossing detected via OCT angiography (20 eyes, 43.5%) was also higher than that detected via FA (P = .047). OCT angiography revealed that venous narrowing (25.5 ± 21.1 μm) was significantly greater in instances of venous overcrossing than in those of arterial overcrossing (46.4 ± 23.7 μm, P = .005). Macular nonperfusion areas (NPAs) were larger in eyes with venous overcrossing than in those with arterial overcrossing (P = .011 for superficial plexus, P = .049 for deep plexus). The peripheral NPA was significantly larger in eyes with venous overcrossing (65.1 ± 35.3 disc area [DA]) than in those with arterial overcrossing (17.2 ± 24.1 DA; P < .001).
CONCLUSIONS: Our findings suggest that BRVO characterized by venous overcrossing may be more prevalent than previously reported, and that there is a significant association between NPA size and AV crossing pattern.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28837791     DOI: 10.1016/j.ajo.2017.08.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Prevalences of segmentation errors and motion artifacts in OCT-angiography differ among retinal diseases.

Authors:  J L Lauermann; A K Woetzel; M Treder; M Alnawaiseh; C R Clemens; N Eter; Florian Alten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-07       Impact factor: 3.117

Review 2.  Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.

Authors:  Yi Tang; Yan Cheng; Shuo Wang; Yongjie Wang; Pengjia Liu; Hong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

3.  RTVue XR AngioVue Optical Coherence Tomography Angiography Software Upgrade Impacts on Retinal Thickness and Vessel Density Measurements.

Authors:  Danuta M Sampson; Noha Ali; Alex Au Yong; Rumaanah Jeewa; Saumya Rajgopal; Deepaysh D C S Dutt; Sharaf Mohamed; Shehata Mohamed; Alex Hansen; Moreno Menghini; Fred K Chen
Journal:  Transl Vis Sci Technol       Date:  2020-02-12       Impact factor: 3.283

4.  Branch Retinal Vein Occlusion: Treatment Outcomes According to the Retinal Nonperfusion Area, Clinical Subtype, and Crossing Pattern.

Authors:  Yuko Iida-Miwa; Yuki Muraoka; Yuto Iida; Sotaro Ooto; Tomoaki Murakami; Kiyoshi Suzuma; Akitaka Tsujikawa
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

5.  Accuracy and Reliability in Differentiating Retinal Arteries and Veins Using Widefield En Face OCT Angiography.

Authors:  Akihiro Ishibazawa; Nihaal Mehta; Osama Sorour; Phillip Braun; Sarah Martin; A Yasin Alibhai; Adnan Saifuddin; Malvika Arya; Caroline R Baumal; Jay S Duker; Nadia K Waheed
Journal:  Transl Vis Sci Technol       Date:  2019-06-28       Impact factor: 3.283

6.  Angiographic Risk Features of Branch Retinal Vein Occlusion Onset as Determined by Optical Coherence Tomography Angiography.

Authors:  Takahiro Kogo; Yuki Muraoka; Yuto Iida; Sotaro Ooto; Tomoaki Murakami; Shin Kadomoto; Yuko Iida-Miwa; Shogo Numa; Masahiro Miyake; Manabu Miyata; Akihito Uji; Akitaka Tsujikawa
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.